$2.50
0.114.60%
At close: -
$2.39
-0.11-4.40%
After Hours: Dec 19, 4:09 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for VYNE Therapeutics in recent months.
Browse guidance and forecast on all stocks.